OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $853
2024-06-30 $585
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.003B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.781B 26.81
Intuitive Surgical (ISRG) United States $217.430B 113.68
Alcon (ALC) Switzerland $43.790B 29.30
Edwards Lifesciences (EW) United States $40.720B 25.86
IQVIA Holdings (IQV) United States $37.284B 20.54
IDEXX Laboratories (IDXX) United States $35.259B 41.52
DexCom (DXCM) United States $34.017B 51.23
Waters (WAT) United States $24.246B 35.85
STERIS (STE) Ireland $21.575B 24.84
SONOVA HOLDING (SONVY) Switzerland $20.893B 0.00
Hologic (HOLX) United States $16.069B 17.45
Fresenius Medical Care AG KGaA (FMS) Germany $13.597B 13.96
Globus Medical (GMED) United States $12.707B 32.18
Sysmex ADR (SSMXY) Japan $11.852B 37.16
Penumbra (PEN) United States $10.587B 103.70
Masimo (MASI) United States $9.271B 44.86
Glaukos (GKOS) United States $8.829B 0.00
Teleflex (TFX) United States $8.395B 13.39
Integer Holdings (ITGR) United States $4.744B 26.89
Inari Medical (NARI) United States $4.650B 0.00
PROCEPT BioRobotics (PRCT) United States $3.570B 0.00
Veracyte (VCYT) United States $3.336B 100.12
LivaNova (LIVN) United Kingdom $2.642B 15.25
Nihon Kohden (NHNKY) Japan $2.325B 17.66
Tandem Diabetes Care (TNDM) United States $2.299B 0.00
Elekta AB (EKTAY) Sweden $2.235B 20.10
TransMedics (TMDX) United States $2.080B 65.93
Integra LifeSciences Holdings (IART) United States $1.918B 10.02
Alphatec Holdings (ATEC) United States $1.614B 0.00
Artivion (AORT) United States $1.290B 85.50
RxSight (RXST) United States $1.286B 0.00
Pulse Biosciences (PLSE) United States $1.152B 0.00
Paragon 28 (FNA) United States $0.979B 0.00
AxoGen (AXGN) United States $0.831B 0.00
Mesa Laboratories (MLAB) United States $0.787B 18.55
IRadimed (IRMD) United States $0.752B 40.63
AVANOS MEDICAL, INC (AVNS) United States $0.729B 12.39
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
SiBone (SIBN) United States $0.698B 0.00
OrthoPediatrics (KIDS) United States $0.657B 0.00
Treace Medical Concepts (TMCI) United States $0.587B 0.00
Semler Scientific (SMLR) United States $0.576B 30.30
Pacific Biosciences Of California (PACB) United States $0.496B 0.00
ClearPoint Neuro (CLPT) United States $0.494B 0.00
AngioDynamics (ANGO) United States $0.488B 0.00
Delcath Systems (DCTH) United States $0.486B 0.00
NeuroPace (NPCE) United States $0.419B 0.00
CVRx (CVRX) United States $0.418B 0.00
Tactile Systems Technology (TCMD) United States $0.417B 22.57
Alpha Tau Medical (DRTS) Israel $0.279B 0.00
Inogen (INGN) United States $0.258B 0.00
Accuray (ARAY) United States $0.229B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.120B 0.00
Sensus Healthcare (SRTS) United States $0.115B 12.26
Monogram Orthopaedics (MGRM) United States $0.098B 0.00
908 Devices (MASS) United States $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.076B 0.00
InspireMD (NSPR) Israel $0.072B 0.00
Neuronetics (STIM) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Rapid Micro Biosystems (RPID) United States $0.061B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.86
Lucid Diagnostics (LUCD) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.046B 0.00
Microbot Medical (MBOT) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
Aspira Women's Health (AWH) United States $0.007B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00